Peritoneal dialysis in 2022: an accidental renaissance?

Authors

DOI:

https://doi.org/10.22141/2307-1257.11.2.2022.368

Keywords:

peritoneal dialysis, chronic kidney disease stage 5, renal replacement therapy, life expectancy in chronic kidney disease

Abstract

The review focuses on peritoneal dialysis as a renal replacement therapy for stage 5 chronic kidney disease (CKD). About 10 % of the world’s population suffers from CKD, but its prevalence and incidence vary widely across the world due to social and economic conditions. The main areas of renal replacement therapy today are haemodialysis and peritoneal dialysis, the beginning of which is recommended for CKD stage 5. Both me­thods are effective and have similar survival and mortality rates. Both techniques are used successfully around the world, but peritoneal dialysis is less resource-intensive, making it the method of choice in many less affluent countries. The advantages of peritoneal dialysis can be: shorter sessions, limited patient movement, being in the family circle and better quality of life according to the patients themselves. Numerous studies are being conducted to improve the reliability and quality of peritoneal dialysis, including access and prevention of infections.

Downloads

Download data is not yet available.

References

Bello AK, Levin A, Lunney M, et al. Global Kidney Health Atlas: A report by the International Society of Nephrology on the Global Burden of End-stage Kidney Disease and Capacity for Kidney Replacement Therapy and Conservative Care across World Countries and Regions. Brussels, Belgium: International Society of Nephrology; 2019. 172 p.

Kidney Disease: Improving Global Outcomes (KDIGO); CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1):1-150.

Yang CW, Harris DCH, Luyckx VA, et al. Global case studies for chronic kidney disease/end-stage kidney disease care. Kidney Int Suppl (2011). 2020 Mar;10(1):e24-e48. doi:10.1016/j.kisu.2019.11.010.

Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in Developed Countries. Kidney Int Rep. 2019 Dec 18;5(3):263-277. doi:10.1016/j.ekir.2019.12.003.

Ameh OI, Ekrikpo UE, Kengne AP. Preventing CKD in Low- and Middle-Income Countries: A Call for Urgent Action. Kidney Int Rep. 2019 Dec 23;5(3):255-262. doi:10.1016/j.ekir.2019.12.013.

Sola L, Levin NW, Johnson DW, et al. Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis. Kidney Int Suppl. 2020 Mar;10(1):e55-e62. doi:10.1016/j.kisu.2019.11.009.

Luyckx VA, Smyth B, Harris DCH, Pecoits-Filho R. Dialysis funding, eligibility, procurement, and protocols in low- and middle-income settings: results from the International Society of Nephrology collection survey. Kidney Int Suppl. 2020 Mar;10(1):e10-e18. doi:10.1016/j.kisu.2019.11.005.

Klinger M, Madziarska K. Mortality predictor pattern in hemodialysis and peritoneal dialysis in diabetic patients. Adv Clin Exp Med. 2019 Jan;28(1):133-135. doi:10.17219/acem/76751.

Swanepoel CR, McCulloch MI, Abraham G, et al. Challenges for sustainable end-stage kidney disease care in low-middle-income countries: the problem of the workforce. Kidney Int Suppl. 2020 Mar;10(1):e49-e54. doi:10.1016/j.kisu.2019.11.007.

GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020 Feb 29;395(10325):709-733. doi:10.1016/S0140-6736(20)30045-3.

Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8. doi:10.1053/j.ajkd.2016.12.004.

Sanabria RM, Vesga JI, Johnson DW, et al. Dialysis Outcomes in a Middle-Income Country: An Updated Comparison of Patient Mortality between Hemodialysis and Peritoneal Dialysis. Blood Purif. 2021 Dec 10:1-11. doi:10.1159/000520518.

Bitar W, Helve J, Honkanen E, Rauta V, Haapio M, Finne P. Similar survival on home hemodialysis and automated peritoneal dialysis: an inception cohort study. Nephrol Dial Transplant. 2021 Aug 7:gfab233. doi:10.1093/ndt/gfab233.

Hausinger R, Schmaderer C, Heemann U, Bachmann Q. Innovations in peritoneal dialysis. Nephrologe. 2022;17(2):85-91. doi:10.1007/s11560-021-00542-x. (in German).

Wilkie M, Davies S. Peritoneal Dialysis in the time of COVID-19. Perit Dial Int. 2020 Jul;40(4):357-358. doi:10.1177/0896860820921657.

Finderup J, Jensen JD, Lomborg K. Shared decision-making in dialysis choice has potential to improve self-management in people with kidney disease: A qualitative follow-up study. J Adv Nurs. 2021 Apr;77(4):1878-1887. doi:10.1111/jan.14726.

Tran PQ, Nguyen NTY, Nguyen B, Bui QTH. Quality of life assessment in patients on chronic dialysis: Comparison between haemodialysis and peritoneal dialysis at a national hospital in Vietnam. Trop Med Int Health. 2022 Feb;27(2):199-206. doi:10.1111/tmi.13709.

Chrifi Alaoui A, Touti W, Al Borgi Y, Sqalli Houssaini T, El Rhazi K. Comparison of quality of life in end-stage renal disease patients undergoing hemodialysis and peritoneal dialysis in a Moroccan city. Semin Dial. 2022 Jan;35(1):50-57. doi:10.1111/sdi.13034.

Yu JY, Kim JS, Hong CM, et al. Psychological distress of patients with end-stage kidney disease undergoing dialysis during the 2019 coronavirus disease pandemic: A cross-sectional study in a University Hospital. PLoS One. 2021 Dec 3;16(12):e0260929. doi:10.1371/journal.pone.0260929.

Vera M, Cheak BB, Chmelíčková H, et al. Current clinical practice in adapted automated peritoneal dialysis (aAPD)-A prospective, non-interventional study. PLoS One. 2021 Dec 9;16(12):e0258440. doi:10.1371/journal.pone.0258440.

Cullis B, Al-Hwiesh A, Kilonzo K, et al. ISPD guidelines for peritoneal dialysis in acute kidney injury: 2020 update (adults). Perit Dial Int. 2021 Jan;41(1):15-31. doi:10.1177/0896860820970834.

Agarwal A, Whitlock RH, Bamforth RJ, et al. Percutaneous Versus Surgical Insertion of Peritoneal Dialysis Catheters: A Systematic Review and Meta-Analysis. Can J Kidney Health Dis. 2021 Nov 8;8:20543581211052731. doi:10.1177/20543581211052731.

Szeto CC, Ng JK, Wing-Shing Fung W, et al. Extended antibiotic therapy for the prevention of relapsing and recurrent peritonitis in peritoneal dialysis patients: a randomized controlled trial. Clin Kidney J. 2021 Jan 17;14(3):991-997. doi:10.1093/ckj/sfaa256.

Farkas A, Oikonomou K, Ghanbar M, et al. Population Pharmacokinetics of Intraperitoneal Gentamicin and the Impact of Varying Dwell Times on Pharmacodynamic Target Attainment in Patients with Acute Peritonitis Undergoing Peritoneal Dialysis. Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0167921. doi:10.1128/AAC.01679-21.

Bennett PN, Bohm C, Harasemiw O, et al. Physical activity and exercise in peritoneal dialysis: International Society for Peritoneal Dialysis and the Global Renal Exercise Network practice recommendations. Perit Dial Int. 2022 Jan;42(1):8-24. doi:10.1177/08968608211055290.

Lee L, Scholes-Robertson N, Manera K. Exercising my right as a patient: Reflections on physical activity and exercise in peritoneal dialysis. Perit Dial Int. 2022 Jan;42(1):3-5. doi:10.1177/08968608211064152.

Devia M, Vesga J, Sanchez R, Sanabria RM, Figueiredo AE. Development of an instrument to assess self-management capacity of patients receiving peritoneal dialysis: CAPABLE. Perit Dial Int. 2022 Jul;42(4):370-376. doi:10.1177/08968608211059897.

Published

2022-07-13

How to Cite

Ivanov, D. D. (2022). Peritoneal dialysis in 2022: an accidental renaissance?. KIDNEYS, 11(2), 108–112. https://doi.org/10.22141/2307-1257.11.2.2022.368

Issue

Section

Looking at the problem

Most read articles by the same author(s)